Category: Uncategorized

IN THE MATTER OF DR. NEIL KAMAL ANAND, MD…PROSECUTORIAL MALFEASANCES: JUDGE CHAD KENNY VACATE THIS VERDICT !! RUAN IS THE LAW OF THE LAND.

“IF EVER ONE THINKS THEY’RE TOO SMALL TO MAKE CHANGES, THEN THEY HAVE NEVER SLEPT WITH A MOSQUITO !!!” NORMAN … More

MONDAY APRIL 14, 2025: PODCAST UPDATE AND REVIEW AS ANAND’S TRIAL GOES TO JURY: D.E.A.’s ANN MILGRAM, D.O.J’s AUSA GLENN LEON ARE DESTROYING THE BEST DOCTORS IN AMERICA, DR’s RUAN, NORRIS, ANAND, WRENN, HANSEN, LEWIS, BRIZUELA, et al., “OUTSIDE THE USUAL PRACTICE OF MEDICINE”

The government prosecutor added a litany of erroneous, misleading but scandalous and headline-grabbing analytics suggesting that on some days in 2015 services were billed for more than 24 hours of work and that my practice sent bills on deceased Medicare beneficiaries after the date of death.

The government investigators and prosecutor believed that this minority Muslim physician of Syrian origin who is solo practicing, will quickly relent and submit to a plea agreement. Dr. Rifai is seeking declaratory and injunctive relief to halt an administrative process initiated by the DEA.

He argues that the DEA’s actions, including the use of an administrative subpoena and the requirement to participate in a hearing before an Administrative Law Judge, violate his constitutional rights, specifically his Fourth Amendment right against unreasonable searches and seizures and his Fifth Amendment right against self-incrimination, especially in light of a pending criminal case against him.

DONALD SULLIVAN RPH., PHD., THE FOLSON AMICUS BRIEF AND THE ABSURDITY OF MEDICAL EXPERTS LIKE DR. TIMOTHY E. KING, MD

his document is an amicus brief submitted by Jack Folson, an expert in pharmacy practice, concerning the case between the Drug Enforcement Administration (DEA) and Pronto Pharmacy. Folson argues that the court should consider the specialized nature of pharmacy practice, particularly in pain management and compounding, when evaluating Pronto Pharmacy’s actions. He contends that the DEA’s understanding of pharmacy standards, influenced by cases involving standard chain pharmacies, does not appropriately apply to a specialty pharmacy like Pronto. The brief aims to enlighten the court about the complexities of pain management, compounding, and the potential negative consequences of the DEA’s actions on patient care and the pharmacy profession.

Key Topics

Pharmacy Standard of Care

Drug Enforcement Administration

Pain Management Specialty

Pharmacy Compounding Practices